IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.697
+0.019 (2.74%)
At close: Dec 5, 2025, 4:00 PM EST
0.714
+0.017 (2.45%)
After-hours: Dec 5, 2025, 7:59 PM EST

IO Biotech Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for IO Biotech stock have an average target of 3.50, with a low estimate of 3.00 and a high estimate of 4.00. The average target predicts an increase of 402.37% from the current stock price of 0.70.

Analyst Consensus: Buy
Target Low Average Median High
Price $3.00 $3.50 $4.00 $4.00
Change +330.60% +402.37% +474.14% +474.14%
* Price targets were last updated on Oct 22, 2025.

Analyst Ratings

The average analyst rating for IO Biotech stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy 110000
Buy 221222
Hold 002222
Sell 000000
Strong Sell 000000
Total 333444

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Piper Sandler
Piper Sandler
Buy
Maintains
$10$3
Buy Maintains $10$3 +330.60% Oct 22, 2025
TD Cowen
TD Cowen
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Sep 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Sep 29, 2025
Morgan Stanley
Morgan Stanley
Buy
Maintains
$6$4
Buy Maintains $6$4 +474.14% Aug 12, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +1,622.41% Apr 1, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
11.02M
EPS This Year
-1.19
from -1.45
EPS Next Year
-0.45
from -1.19
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
------11.02M
Revenue Growth
-------
EPS
-82.36-17.30-2.48-1.98-1.45-1.19-0.45
EPS Growth
-------
Forward PE
-------
No. Analysts -----77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a 31.2M
Avg n/a 11.0M
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027
High -1.00 -0.19
Avg -1.19 -0.45
Low -1.27 -0.65

EPS Growth

EPS Growth 202520262027
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.